Dupuytren's Disease, (DD), is a fibroproliferative condition of the palmar fascia in the hand, typically resulting in permanent contracture of one or more fingers. This fibromatosis is similar to scarring and other fibroses in displaying excess collagen secretion and contractile myofibroblast differentiation. In this report we expand on previous data demonstrating that POSTN mRNA, which encodes the extra-cellular matrix protein periostin, is up-regulated in Dupuytren's disease cord tissue relative to phenotypically normal palmar fascia. We demonstrate that the protein product of POSTN, periostin, is abundant in Dupuytren's disease cord tissue while little or no periostin immunoreactivity is evident in patient-matched control tissues. The relevance of periostin up-regulation in DD was assessed in primary cultures of cells derived from diseased and phenotypically unaffected palmar fascia from the same patients.
Introduction
Dupuytren's Disease (DD) is characterised by the progressive development of a scar-like, collagen-rich cord within the palmar fascia of the hand that typically results in permanent finger contracture. While DD can occur in both sexes and at all ages [1, 2] , this fibromatosis is most common in males older than 70 years of Northern European descent [3, 4] with a reported prevalence as high as 39% in within some sections of this population [2] . The condition is currently incurable and is most commonly treated by surgical resection of the disease cord.
Surgical resection has the disadvantages of being painful, requiring prolonged post-operative rehabilitation and disease recurrence rates after surgery are high [5] [6] [7] [8] [9] . Faced with these challenges, it is not unknown for patients with a history of multiple recurrences and/or surgery associated complications to opt for amputation of the affected finger(s) [10] . A detailed understanding of the cell biology of this condition is required before alternative treatment options including non-surgical molecular therapies can be developed.
Previous studies by several groups have identified POSTN mRNA as a highly upregulated gene transcript in DD nodule and cord tissue relative to phenotypically normal palmar fascia control tissue [11] [12] [13] . POSTN encodes the extra-cellular matrix protein Periostin, originally identified as a TGFβ-1-inducible protein in osteoblasts (Osteoblast-Specific Factor-2 [14] ). Periostin is highly expressed during the earliest stages of bone fracture repair [15] and vascular injury [16] and periostin signaling induces the expression of molecules associated with cutaneous wound repair such as collagen and fibronectin [17, 18] . A role in cancer cell metastasis has also been suggested, as periostin is a recognize component of stromal reactions in a variety of tumor types [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . While DD shares some characteristics with each of these repair and disease processes, the role(s) of periostin in this fibromatosis are yet to be determined.
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In this report we expand on these previous reports by assessing tissue lysates and sections of DD cord by real time PCR and in situ hybridization studies respectively. Further, we demonstrate that the protein product of POSTN, periostin, is abundant in involutional DD cord tissue relative to adjacent phenotypically normal palmar fascia from the same patients by western immunoblotting and immunohistochemistry. We have assessed the effects of recombinant periostin on primary DD and PF cell proliferation, α smooth muscle actin induction, apoptosis and contractility by adding this molecule to a type-1 collagen-enriched environment designed to more closely replicate in vivo conditions. Finally, we have interpreted our findings to speculate on the roles periostin might play in promoting DD cell development, as well as its potential to promote transition of adjacent palmar fascia to a disease phenotype.
Methods

Clinical Specimens
Nine surgically resected Dupuytren's Disease (DD) cord samples and small samples of 
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Total RNA Extraction
Approximately 100 mg tissue samples were crushed into small fragments on aluminum foil over dry ice, snap-frozen in liquid Nitrogen and ground in a mortar and pestle in 1 ml of TRIzol reagent (Invitrogen, Burlington, ON). Samples were transferred to 1.5 ml microcentrifuge tubes and total RNA was isolated using the TRIzol procedure. This RNA was then further purified using the RNeasy Minikit (Qiagen, Mississauga, ON). Aliquots (3 µl) were screened using an Agilent 2100 Bioanalyzer (Agilent Technologies, Mississauga, ON) and only high quality RNA samples were submitted to London Regional Genomic Center (www.lrgc.ca)
for Microarray analysis on the Human Genome U133 Plus 2.0 Array (Affymetrix, Santa Clara CA).
Microarray Expression Analysis
Microarrray experiments were performed to identify genes that are differentially expressed in DD-affected palmar fascia versus those derived from normal fascia. Analysis was performed by the London Regional Genomic Center (www.lrgc.ca) using the Human Genome U133 Plus 2.0 Array (Affymetrix, Santa Clara, CA). The data were analyzed using the this small sample number analysis to give a false positive rate of 10%.
Real Time PCR
Confirmatory Real Time PCR quantitation of POSTN mRNA expression was performed on
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an ABI Prism 7700 (Applied Biosystems, Foster City, CA) using the comparative Ct method. In brief, TRIzol reagent and RNeasy® Mini Kits (Qiagen, Mississauga, ON) were used to isolate total RNA from additional surgically resected tissues. RNA quality was again determined on an Agilent 2100 Bioanalyzer and 10µg of high quality total RNA was reverse transcribed into cDNA first strand using the High-Capacity cDNA Archive Kit (Applied Biosystems) in accordance with the manufacturer's instructions. For validity, the comparative Ct method requires that the amplification efficiency of the target and endogenous control transcripts to be equivalent. To assess this, dilutions of cDNA first strand corresponding to 1000ng, 500ng , 100ng, 50ng, 10ng and 0ng were introduced into the PCR reactions. Coupled with the target gene, POSTN, endogenous control gene products were amplified by gene specific probe sets containing TaqMan® MGB probes labeled with 6-FAM™ (Applied Biosystems, POSTN,
Hs00170815_m1, endogenous control GAPDH 4333764F). Triplicate reactions of each dilution
were performed (50 µl samples) in a 96-well plate format using SDS instrumentation (Applied Biosystems) for 45 cycles. Target and endogenous control reaction were run in separate wells in triplicate at each concentration. To determine if the target and endogenous control gene products amplified with the same efficiency, the ∆C T value (C T target /C T endogenous control ) was plotted against the log input cDNA to create a semi-log regression line. A "pass" value of <0.2 for the slope of ∆C T vs. log input was used in this study.
Western immunoblotting
Surgically resected DD tissue and patient-matched adjacent normal fascia were snap-frozen in liquid nitrogen and protein extracts were prepared using a tissue biopulveriser and PhosphoSafe protein Extraction Buffer (VWR, Mississauga, ON). Cell lysates were prepared in PhosphoSafe A C C E P T E D M A N U S C R I P T
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protein Extraction Buffer in accordance with the manufacturer's instruction. After centrifuging the extract to remove insoluble material, equivalent protein quantities were determined by BCA analysis, subjected to immunoblotting and probed with antibodies against periostin (Santa Cruz Biotechnology, Santa Cruz CA), α smooth muscle actin (AbCam, Cambridge MA) and β Actin (Labvision, Fremont, CA). Immunoblot analysis was carried out using standard procedures and immunoreactivity was visualized using Enhanced Chemiluminescence (ECL).
Immunohistochemistry
Four surgically resected DD cord and four patient-matched, phenotypically normal palmar fascia samples were fixed in 10% formalin prior to dehydration, paraffin embedding and microtome sectioning. Paraffin-embedded specimens were sectioned (5 µm), dewaxed, rehydrated and treated with a 3% hydrogen peroxide solution to quench endogenous peroxidase activity. Slides A C C E P T E D M A N U S C R I P T
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Plasmid vectors and In Situ Hybridization
A 391-bp fragment encoding the N-terminus of periostin was excised using BamHI and EcoRI digestion of a human POSTN cDNA (a kind gift from Dr. Xiao-Fan Wang, Duke University Medical Center, Durham, North Carolina) [26] . This fragment was cloned into pBluescript SK (Stratgene, La Jolla, CA). Sense and antisense probes were generated in the presence of 35 S with T7 and T3 RNA polymerases from plasmid linearized with Bam HI and EcoRI, respectively.
The in situ hybridization protocol used in this study has been described previously [30, 31] . In 
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Cell proliferation assays
The 
Apoptosis assays
The Cell Death Detection ELISA (Roche Applied Science, Laval,QC) was used to detect histone-associated DNA fragments from mono-and oligonucleosomes as a marker for apoptotic cells. In brief, 1.2x10 5 cells per well were plated into 6 well plates coated with 1.9 mg/ml of type-1 collagen in 1ml of 10%FBS in αMEM in 37C in 5% CO2. After 3 days the cells were washed and made serum free for 12 hours before treatment with 0.5 or 2 μg/mL of recombinant Pn or vehicle in MCDB /1%FBS. MCDB media was utilized for these experiments as it is designed to enhance the long-term survival of human fibroblast-like cells in low serum conditions. After 4 days of treatment, the cells were washed with PBS and 1mL of 0.25mg/ml
Collagenase XI (Sigma-Aldrich, St Louis, MO) was added to each well to remove cells from collagen. The cells were collected by centrifugation (300x g for 5 min) and resuspended in serum free medium. The cells were then spun at 1500X g for 5min, the supernatant discarded
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and the cell pellet was resuspended with 500ul of lysis buffer and incubated at room temperature for 30 minutes. The lysate was then spun at 20,000x g for 10 minutes and the supernatant, which consist of the cytoplasmic fraction, was assayed using the ELISA according to the manufacturer's instructions. All experiments were performed on a minimum of 3 matched cell lines and performed in triplicate.
Stressed Fibroblast Populated Collagen Lattice (sFPCL) contractility assays
Collagen contraction assays were carried out using DD and control PF primary cell cultures established from diseased and adjacent uninvolved fascia from the same patients based on
Tomasek et al [32] . Primary cultures (passages 3-6) were grown as three-dimensional Fibroblast Populated Collagen Lattices. Collagen lattices were cast in 24-well tissue culture trays with each well containing 400 µl collagen (final collagen concentration of 1.9 mg/ml), 100
µl neutralization solution, 1 x 10 5 cells and 2 µg/ml Pn or vehicle. FPCLs were maintained in a αMEM supplemented with 2% FBS and 1% antibiotic-antimycotic solution at 37 o C in 5% CO 2 for 3 days. During this time, the primary fibroblasts in three dimensional collagen cultures respond to stress within the polymerized lattice and differentiate towards a contractile myofibroblast phenotype [33] . After 3 days in culture, all sFPCLs were simultaneously released from the sides and bottoms of the wells using a glass rod, allowing the differentiated myofibroblasts to contract the lattice. Lattices floating in tissue culture medium were digitally scanned at set intervals and the areas of each lattice were determined using the freehand tool in ImageJ software. Sequential area calculations were then normalized to the area prior to release.
All experiments were performed on a minimum of 3 matched cell lines and each assay was performed in triplicate.
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Statistical Analyses
Statistical analysis was conducted using SPSS v. 16 and Microsoft Excel 2007 statistical software. Paired t-tests were conducted on periostin and vehicle treated DD or PF cells at each time interval for cell proliferation, contractility, and apoptosis. Results were deemed significant when p < 0.05.
Results
POSTN mRNA and periostin are abundant in DD cord relative to control palmar fascia
We performed a small scale Affymetrix microarray analysis on total RNA extracted from two DD cord samples and one DD nodule sample for comparison with two patient-matched phenotypically normal palmar fascia samples and one additional normal palmar fascia sample obtained during carpal tunnel release surgery. As shown in Table 1 , fourteen gene transcripts were identified as differentially regulated in all three DD samples by subsequent analysis of the data using SAM. The delta value was 7.539548891 and the FDR of this pilot study was 0.10138546, indicating that one of the genes detected maybe represent a random occurrence.
Despite the small sample size, our data were consistent with previous larger scale studies [11, 12] in identifying two POSTN mRNA transcripts (gene IDs AY140646 and D13665) as upregulated in DD tissue relative to controls.
Rather than expand our microarray analysis, we opted to confirm the changes in POSTN mRNA expression in additional surgical samples using real time PCR. POSTN mRNA levels were found to be highly variable across different sections of each DD cord, potentially reflecting the non-homogeneity of these surgically-resected tissues. Despite this within-sample variability,
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mean POSTN mRNA levels were confirmed as significantly increased (p < 0.05) in all the surgically resected DD cord tissue samples relative to control samples (Fig.1) .
To identify the cellular source(s) of POSTN mRNA in DD cord tissue, in situ hybridization studies were performed utilizing a POSTN cDNA on three additional DD cord and PF samples.
As shown in Fig.2 (A and B) , hybridization with the antisense POSTN mRNA probe resulted in intense signal in densely cellular sections of the cord, where the most abundant cell type displayed a fibroblastic morphology, consistent with previous reports [32, [34] [35] [36] . Adjacent structures incorporated into the fibrotic cord, (such as the eccrine sweat duct shown in Fig 2, arrow), displayed relatively low levels of antisense POSTN mRNA probe hybridization. In contrast to signal evident in DD cord tissue, antisense POSTN mRNA probe signal was uniformly low in the less cellular, patient-matched, phenotypically normal palmar fascia (Fig.2, 
B and C).
The sense POSTN mRNA probe exhibited uniform, low level background signal in all sections of the cord tissue, demonstrating the specificity of the antisense POSTN mRNA probe (Fig.2, D 
and E).
To determine if increased level of POSTN mRNA in DD tissue correlated with increased periostin levels, additional DD cord, nodular tissue and patient-matched, uninvolved palmar fascia samples were lysed and immunoblotted with periostin antibody. As shown in the representative immunoblot in Fig.3A , a major band with mobility of approximately 90kDa, corresponding to the predicted molecular weight of periostin (91.7 kDa), was evident in the DD cord tissue and nodule lysates assessed while little or no immunoreactivity was detected in patient-matched, uninvolved palmar fascia. Additional, less intense bands at lower molecular weights were evident in a subset of DD cord tissue samples, potentially representing degraded periostin. While periostin levels assessed by western immunoblotting were noted to vary M A N U S C R I P T
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between patient-matched residual cord and nodule samples in a few instances (an example is shown in Fig. 3Ac) , the majority of densely cellular DD cord samples displayed readily detectable levels of periostin. Immunohistochemistry revealed strong immunoreactivity throughout cellular DD cord tissue while relatively little periostin immunoreactivity was evident in patient-matched phenotypically normal palmar fascia (Fig.3B, a and b) . Replacement of the primary periostin antibody with IgG and subsequent addition of biotinylated secondary antirabbit antibody followed by DAB addition confirmed the specificity of the primary antibody interactions in these sections (data not shown).
Correlation of in vivo and in vitro periostin levels for primary cell culture
To determine appropriate levels of exogenous periostin treatment to approximate in vivo approximate in vivo levels. This range correlated with a previous report using 0.1µg/ml to 5µg/ ml periostin to assess apoptosis in cultures of pancreatic cancer cells [37] .
Effects of periostin on apoptosis of DD and PF cells in collagen culture
To determine if exogenous periostin could modify the baseline apoptosis of DD or PF cells in culture, three primary DD and three patient-matched PF cell lines were cultured for 4 days in 1% 
Effects of periostin on proliferation of DD and PF cells in collagen culture
To determine if periostin affected the proliferative phenotype of DD or PF cells, cultures were assessed using the WST-1 assay with vehicle or 2.0 µg/ml of recombinant periostin incorporated in type-1 collagen over 6 days in α MEM with 2% FBS. As shown in Fig.6 , periostin had no
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significant effect on the basal proliferation rate of DD cells. In contrast, patient-matched PF cells exhibited a consistent increase in cellular proliferation in all patient lines tested with statistical significance being achieved by 6 days post treatment (p < 0.05).
Effects of periostin on contraction and α smooth muscle actin levels of DD and PF cells in collagen culture
As DD is a contractile fibrosis characterized by myofibroblast abundance, we utilized stressed Fibroblast Populated Collagen Lattice (sFPCL) assays to assess the effects of exogenous periostin on DD and PF cell contractility. The degree of contraction of sFPCLs correlates with the degree of myofibroblast differentiation in these cultures [33] . We have previously demonstrated that DD cells display an increase in contractility in stressed FPCL assays compared to patient matched PF cells [38] . As shown in Fig.7A contractility and induction of α smooth muscle actin [32] . These data contrasted with periostintreated PF cells in sFPCL culture at 48 hours after release, where α smooth muscle actin levels were either unchanged, or occasionally modestly enhanced, by periostin treatment relative to vehicle treated controls. M A N U S C R I P T
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Discussion
The most widely accepted theory on the pathogenesis of DD is that resident fibroblasts in the palmar fascia are stimulated by as-yet unidentified factor(s) to undergo differentiation into a "nodule" of myofibroblasts, which in turn develop into a contractile disease "cord". The contractile forces that can, dependent on the site of the nodule within the palmar fascia, produce finger contracture are generated by these myofibroblasts. Much of this theory is based on the temporal correlation between the appearance of a densely cellular nodule containing randomly orientated spindle-shaped fibroblasts with increased α-smooth muscle actin expression (Luck's proliferative phase [39] ) and the orientation of these cells along lines of tension corresponding to the onset of contraction (Luck's involution phase) [32, 35, [39] [40] [41] [42] [43] . It is apparent from many studies that nodular tissue is considered to be inherently more "biologically active" than the contracted cord tissue itself, which contains sections of densely collagenous and relatively acellular tissue [11, [44] [45] [46] . Despite this, primary cells derived from surgically resected nodular and cord tissue are very similar in appearance, in response to disease-associated cytokines such as TGFβ [44, 46] and in gene expression [13] . As surgically resected DD cords have been recognized for more than 50 years to contain both cell-dense and relatively acellular regions (Luck's "nodule-cord unit" [39] ), we suggest that these data can be explained by primary culture selecting for a proliferative cellular pool within the cord that is common to both disease stages.
These observations are consistent with our findings of abundant periostin in densely cellular sections of cord samples while residual cord samples from the same patient can display low levels of periostin (an example of which is shown in Fig. 3Ac ). Based on these observations, we have taken advantage of the relative abundance of surgically resected cord samples containing
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densely cellular tissue to derive our primary DD cells and used phenotypically normal palmar fascia tissue from the same patients as controls for our comparative analyses.
Originally identified as a TGFβ-1-inducible protein specific to mouse osteoblasts [14] , periostin is now recognized as a ECM component of many collagen-rich connective tissues that are subjected to mechanical stress-tension [47] . Reports of POSTN mRNA up-regulation [11] [12] [13] and our data shown here demonstrating abundant periostin in a contractile fibrosis like DD, therefore, are not altogether unexpected. Periostin is a member of a subset of secreted ECM-associated molecules termed "matricellular" proteins [48] [49] [50] that modulate interactions with structural components of the ECM, such as collagens, and a variety of cell surface receptors, such as integrins, to regulate cellular differentiation in development [51] and connective tissue disease [52] . Based on these data and numerous studies demonstrating that the ECM can potently regulate cellular differentiation [53] [54] [55] [56] [57] , where possible we incorporated our periostin treatments into the collagen substrate, rather than simply amending the tissue culture media, to more closely replicate in vivo conditions.
Periostin has been shown to promote collagen fibrillogenesis and alter the deposition of ECM proteins in other systems [58] and larger scale microarray studies have identified COL1A1mRNA, encoding the collagen α1 component of heterotrimeric and homotrimeric type-1 collagen [59] , as up-regulated in DD cord [11, 12] . Excess collagen deposition and changes in ECM components are established hallmarks of DD [11, [60] [61] [62] and collagen in DD cords has been previously reported to feature increased levels of hydroxylysine and reducible cross-links, features also evident in scar tissue and indicative of abnormal deposition [63] . As variations in collagen type can also regulate fibroblast-mediated contractility in vitro [64] , it is possible that periostin may play a role in collagen production, fibrillogenesis and cross-linking in DD. We are
currently addressing whether ECM-associated periostin can induces COL1A1 mRNA expression in DD or PF cells and, if so, if this contribution to the ECM affects cellular contractility of these cells in sFPCLs. We are also interested in determining whether periostin specifically alters collagen cross-linking of these lattices and if this aspect contributes to the effects of periostin on FPCL contraction of DD cells.
We have demonstrated that collagen-bound periostin induces α-smooth muscle actin production and a significant increase in collagen lattice contraction by DD fibroblasts, consistent with this matricellular molecule promoting myofibroblast differentiation of these cells. While periostintreated cultures of PF cells did not display a significant increase in contractility at any time point relative to vehicle treated cells, a consistent trend towards increased contractility was evident in the multiple experiments performed. We have also noted that α smooth muscle actin levels in PF cells were occasionally, but not consistently, up-regulated by periostin treatment in some cultures (data not shown). These data have led us to speculate that exposure to periostin in the ECM may induce PF cells to differentiate from a fibroblast phenotype toward a "protomyofibroblast" phenotype, a transition phase prior to commitment to a differentiated myofibroblast phenotype, with inconsistently up-regulated α smooth muscle actin levels [65] . It will be interesting to test if a longer-term treatment of PF cells with ECM-associated periostin induces PF cells to take on a DD cell phenotype.
Myofibroblasts have been shown to utilize the PI3 kinase/Akt signaling pathway to avoid apoptosis in abnormal scarring [66] [67] [68] and periostin signaling has been shown to promote avoidance of apoptosis through this pathway [29, 37] . While there was a consistent trend towards a decrease in DD cells apoptosis with periostin treatment, this did not achieve statistical significance in our in vitro collagen culture conditions (DD cells treated with vehicle vs 0.5
µg/ml recombinant periostin, p = 0.075; PF cells treated with vehicle vs 2.0 µg/ml recombinant periostin, p = 0.065). Interestingly, multiple assessments of DD and PF cell lines cultured in type-1 collagen in the absence of periostin (treated with periostin vehicle, Phosphate Buffered Saline/0.1% BSA) revealed that DD cells consistently display a higher level of baseline apoptosis (p < 0.05) than their patient-matched PF controls. We speculate that these data reflect the sensitivity of DD myofibroblasts to the relatively low stress-tension of a collagen substrate relative to tissue culture plastic [69] , further emphasizing the importance of modeling fibroproliferative diseases in culture systems that mimic the in vivo disease environment [70] .
As previously discussed, it is possible that that longer term exposure to periostin may be required to detect any significant effects on DD cell apoptosis in vitro. As periostin up-regulation is associated with connective tissues with altered mechanical stress-tension [47] , it will be interesting to determine whether the combination of mechanical tension and periostin in a collagenous environment will affect DD cell avoidance of apoptosis.
Our observations of significant increases in both proliferation and apoptosis in primary PF cells, cultured on collagen-coated dishes with exogenous periostin, are intriguing. We speculate that simultaneous periostin-induced proliferation and apoptosis of PF cells may be a component of their transition to a myofibroblast-like phenotype, although whether this implies a selection process for a subset of PF cells is currently unclear. Both DD and PF cells exhibit a basal rate of proliferation in our collagen-based two-dimensional cultures, unlike sFPCL cultures [38] , possibly reflecting data indicating that sFPCL culture induces myofibroblast differentiation [43] and that terminally differentiated myofibroblasts do not proliferate [71] . Periostin was found to have no discernable effect on the basal proliferation rate of DD cells while inducing a significant increase in proliferation of PF cells. The induction of fibroblast proliferation followed by M A N U S C R I P T
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differentiation into contractile fibroblasts is a normal component of the proliferative phase of cutaneous wound repair [72] and we speculate that one role of periostin may be to induce PF cells to initially proliferate and then eventually differentiate towards a proto-myofibroblast phenotype [65] with contractile bundles composed of cytoplasmic actins [73] . In contrast, primary DD cells in culture may already be in this proto-myofibroblast state, explaining why periostin treatment readily induced their differentiation to α smooth muscle actin expressing myofibroblasts. It is currently unclear whether the primary cells derived from DD cord tissue represent de-differentiated myofibroblasts or selection of a resident sub-population of protomyofibroblasts in these tissues. Irrespective, it is clear from the induction of α smooth muscle actin and enhanced contractility reported here that periostin consistently induced these cells to assume a highly contractile, myofibroblast phenotype.
Clinically, full-thickness skin grafts (in which the dermis is included) have been shown to attenuate recurrence of DD in some studies [7, [74] [75] [76] , implying that local environment of the DD cord left behind after resection may contain factors that promote disease recurrence. Our in vitro data suggest that PF fibroblasts, derived from the palmar fascia immediately adjacent to DD cord, are sensitive to periostin-induced proliferation. These data lead us to speculate that periostin secreted by DD cells into the surrounding ECM may potentially contaminate the adjacent fascia remaining after resection of the cord, promoting proliferation (and possibly, eventual myofibroblast differentiation) of the resident PF cells. Studies focused on long-term exposure of PF cells to periostin in in vitro culture systems that mimic the in vivo disease environment may shed light on this speculation.
Conclusion
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Periostin is up-regulated component of DD cord that induces α smooth muscle actin formation and contraction primary DD cells. In addition, periostin was found to induce both PF cell proliferation and apoptosis. Further studies will be focused on elucidating the specific signaling pathways stimulated by periostin in these cell types and to determine if this molecule has potential as a target for therapeutic intervention to prevent DD recurrence. FPCLs containing DD or PF cells and either recombinant periostin (2 µg/ml, Pn) or vehicle (Veh) were lysed 48 hours after release and the lysates were subjected to western immunoblotting for α-smooth muscle actin. β actin levels were also assessed to confirm that equal amounts of cell-derived protein was loaded in each well. As shown, addition of 2 µg/ml These immunoblots are representative of three PF and three DD cell lines assessed in triplicate.
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